How to buy GSK shares

GSK shares have fallen 0.84% from their previous closing price (1509.5p). Learn how to easily invest in GSK shares.

GSK
LSE: GSK-GBX
About an hour ago

1496.89p

-12.62p (-0.84%)

The global stock market has taken a big hit recently due to the ongoing coronavirus pandemic. While the GSK share price has also dropped, investors may see it GlaxoSmithKline shares as a safer long-term bet, especially given its history with developing vaccines. GlaxoSmithKline plc (LON:GSK) is a British pharmaceutical company based in Brentford. It is part of the FTSE 100 and helped developed the world’s first malaria vaccine in 2014.

How to buy shares in GSK

  1. Open a brokerage account. Choose from our top broker picks or compare brokers in depth. Then, complete an application.
  2. Fund your account. Add money to your account via bank transfer, debit card or credit card.
  3. Search the platform by ticker symbol. GSK in this case.
  4. Choose an order type. Place a market order or limit order with your preferred number of shares or dollar amount.
  5. Submit the order. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Our top picks for where to buy GSK shares

Fees calculator for buying GSK shares with popular apps

Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.

Quantity of shares

100
Platform Finder Score Account fee Min. initial deposit Trade cost Link
eToro Free Stocks logo
4.3 ★★★★★
£0 $100 £1,526.93
Go to siteCapital at risk
Saxo Share Dealing Account logo
4.3 ★★★★★
0.12% per year £0 £1,512.37
Go to siteCapital at risk
XTB logo
4.4 ★★★★★
£0 £0 £1,504.37
Go to siteCapital at risk
CMC Invest share dealing account logo
4.4 ★★★★★
£0 £0 £1,504.37
Go to siteCapital at risk
Hargreaves Lansdown Fund and Share Account logo
4.2 ★★★★★
£0 £1 £1,516.32
Go to siteCapital at risk
InvestEngine logo
4.4 ★★★★★
0% - 0.25% £100 £1,504.37
Go to siteCapital at risk
Trading212 logo
4.7 ★★★★★
£0 £1 £1,504.37
Read reviewCapital at risk

Full comparison of share dealing platforms

These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Alternative ways to invest in GSK

Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including GSK), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.

GSK is a major part of the London stock exchange, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

Fund5-year performance (to May 2024)Link to invest
Xtrackers FTSE 100 (XDUK)Xtrackers icon36.5540%Invest with HLCapital at risk
HSBC FTSE 100 (HUKX)HSBC icon36.43%Invest with XTBCapital at risk
iShares Core FTSE 100 (CUKX)iShares icon36.30%Invest with eToroCapital at risk
Vanguard FTSE 100 (VUKE)Vanguard icon36.28%Invest with XTBCapital at risk
iShares Core FTSE 100 (Dist)(ISF)iShares icon36.27%Invest with XTBCapital at risk
Invesco FTSE 100 (S100)Invesco icon35.31%Invest with HLCapital at risk
Amundi FTSE 100 (100D)amundi icon35.30%Invest with HLCapital at risk

Is it a good time to buy GSK stock?

Review technicals and fundamentals to help you determine if now's a good time for you to invest.

Technical analysis

View GSK's price performance, share price volatility, historical data and technicals.

Use our graph to track the performance of GSK stock over time.

Historical closes compared with the last close of 1496.885

1 week (2024-07-16)-2.07%
1 month (2024-06-23)-6.94%
3 months (2024-04-23)-8.50%
6 months (2024-01-23)-3.72%
1 year (2023-07-23)7.24%
2 years (2022-07-21)-14.13%
3 years (2021-07-22)5.71%
5 years (2019-07-23)-9.48%

The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Promoted
eToro Free Stocks
Invest in GSK shares
Finder Award
  • Start investing from $50
  • Pay no stamp duty on UK shares
  • Commission-free trading. Other fees may apply.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is GSK under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the GSK P/E ratio, PEG ratio and EBITDA.

GSK's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, GSK's shares trade at around 14x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the United Kingdom stock market as of 09 November, 2023 (10). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, GSK's P/E ratio is best considered in relation to those of others within the industry or those of similar companies.

GSK's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1012. A PEG ratio close to 1 can be interpreted as meaning shares offer reasonable value for the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into GSK's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

However, it's sensible to consider GSK's PEG ratio in relation to those of similar companies.

GSK's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping £10.5 billion.

The EBITDA is a measure of GSK's overall financial performance and is widely used to measure a its profitability.

To put that into context you can compare it against similar companies.

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

  • How to buy Canopy Growth shares

    Ever wondered how to buy shares in Canopy Growth? We explain how and compare a range of providers that can give you access to many brands, including Canopy Growth.

  • How to buy Green Thumb Industries shares

    Ever wondered how to buy shares in Green Thumb Industries? We explain how and compare a range of providers that can give you access to many brands, including Green Thumb Industries.

  • How to buy Curaleaf Holdings shares

    Ever wondered how to buy shares in Curaleaf Holdings? We explain how and compare a range of providers that can give you access to many brands, including Curaleaf Holdings.

  • How to buy Genesis Healthcare shares

    Ever wondered how to buy shares in Genesis Healthcare? We explain how and compare a range of providers that can give you access to many brands, including Genesis Healthcare.

  • How to buy Allergy Therapeutics shares

    Ever wondered how to buy shares in Allergy Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Allergy Therapeutics.

  • How to buy 4D pharma shares

    Ever wondered how to buy shares in 4D pharma? We explain how and compare a range of providers that can give you access to many brands, including 4D pharma.

  • How to buy Aurora Cannabis shares

    Ever wondered how to buy shares in Aurora Cannabis? We explain how and compare a range of providers that can give you access to many brands, including Aurora Cannabis.

  • How to buy Evgen Pharma shares

    Thinking about buying shares in Evgen Pharma? We explain how to do it and compare a range of providers who will give you access to global markets.

  • How to buy Intuitive Surgical shares

    Ever wondered how to buy shares in Intuitive Surgical? We explain how and compare a range of providers that can give you access to many brands, including Intuitive Surgical.

  • How to buy Stryker Corporation shares

    Ever wondered how to buy shares in Stryker? We explain how and compare a range of providers that can give you access to many brands, including Stryker.

Go to site